Endexx Past Earnings Performance
Past criteria checks 3/6
Endexx has been growing earnings at an average annual rate of 31.7%, while the Pharmaceuticals industry saw earnings growing at 1% annually. Revenues have been growing at an average rate of 63.6% per year.
Key information
31.7%
Earnings growth rate
40.9%
EPS growth rate
| Pharmaceuticals Industry Growth | 6.0% |
| Revenue growth rate | 63.6% |
| Return on equity | n/a |
| Net Margin | 148.6% |
| Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Endexx makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 5 | 7 | 5 | 0 |
| 31 Mar 23 | 5 | -2 | 5 | 0 |
| 31 Dec 22 | 1 | -4 | 3 | 0 |
| 30 Sep 22 | 2 | -5 | 5 | 0 |
| 30 Jun 22 | 1 | -18 | 5 | 0 |
| 31 Mar 22 | 1 | -9 | 6 | 0 |
| 31 Dec 21 | 1 | -7 | 6 | 0 |
| 30 Sep 21 | 1 | -7 | 5 | 0 |
| 30 Jun 21 | 1 | -6 | 4 | 0 |
| 31 Mar 21 | 1 | -6 | 3 | 0 |
| 31 Dec 20 | 1 | -9 | 4 | 0 |
| 30 Sep 20 | 1 | -9 | 4 | 0 |
| 30 Jun 20 | 1 | -12 | 6 | 0 |
| 30 Sep 19 | 1 | -8 | 4 | 0 |
| 30 Sep 15 | 0 | -1 | 1 | 0 |
| 30 Sep 14 | 0 | 0 | 1 | 0 |
Quality Earnings: EDXC has high quality earnings.
Growing Profit Margin: EDXC became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EDXC has become profitable over the past 5 years, growing earnings by 31.7% per year.
Accelerating Growth: EDXC has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: EDXC has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-13.2%).
Return on Equity
High ROE: EDXC's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.